en

PRODUCT DETAIL

REYATAZ 300 mg tvrdé kapsuly

Code 50568
MA number EU/1/03/267/008
Product Form: cps dur 30x300 mg (HDPE fľ.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AE Protease inhibitors
J05AE08 Atazanavir
Shelf life: 24
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - known active substance
MA issued: 02.03.2004
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 30.06.2021
eu-flag.png sk-flag.png